RTT-60 (Retatrutide 60-Day Cycle Kit)
Complete 60-day research cycle of retatrutide with structured dose escalation. Includes all vials, a bacteriostatic water supply, and a dosing guide for the
Buy more, save more
Total Price
$400
For research & laboratory use only. Not for human consumption.
Half-Life
~6 days (allows once-weekly dosing)
Administration Route
Subcutaneous injection
60-Day Escalation Kit
All retatrutide vials for the complete dose-titration protocol
Phase 3 Protocol
Mirrors the TRIUMPH trial escalation used in clinical research
Everything Included
Graduated vials + BAC water + dosing card in one kit
Effect Profile
Combined Efficacy
Synergistic Action
Protocol Coverage
Value
Mechanism of Action
Scientific Research
N Engl J Med (2023)
N Engl J Med (2023)
Product FAQs
Stacks Well With
Retatrutide
Triple GLP-1, GIP, and glucagon receptor agonist. Phase 2 data reported up to 24.2% body weight reduction at 12mg weekly dose over 48 weeks.
AOD 9604
Modified fragment of human growth hormone (hGH 177-191) with selective lipolytic activity and no reported effect on blood glucose or IGF-1. Studied for adipose
Related Products
Retatrutide
Triple GLP-1, GIP, and glucagon receptor agonist. Phase 2 data reported up to 24.2% body weight reduction at 12mg weekly dose over 48 weeks.
Tirzepatide
Dual GIP and GLP-1 receptor agonist. Among the most potent metabolic peptides studied to date, with clinical trials reporting up to 21% body weight reduction.
Semaglutide
Long-acting GLP-1 receptor agonist. STEP-1 trial reported 14.9% average body weight reduction at 2.4mg weekly dose over 68 weeks.